Haleon (LON:HLN) Sets New 12-Month Low - Time to Sell?

Key Points

• Haleon plc's stock reached a new 52-week low of GBX 335.10 ($4.56) on Tuesday, with analysts issuing mixed ratings on the stock, leading to a consensus rating of "Hold" and a target price of GBX 436.67.
• The company's recent earnings report showed a net margin of 9.66% and an earnings per share (EPS) of GBX 8.90, with analysts predicting an EPS of approximately 19.50 for the current year.
• Insider selling activity was noted, with Dawn Allen selling 64,329 shares at an average price of GBX 376, raising concerns over investor confidence as insiders own only 0.01% of the stock.

Haleon plc (LON:HLN - Get Free Report) shares reached a new 52-week low on Tuesday . The company traded as low as GBX 335.10 ($4.51) and last traded at GBX 346.90 ($4.67), with a volume of 119930961 shares traded. The stock had previously closed at GBX 356.70 ($4.81).

Analyst Upgrades and Downgrades

HLN has been the topic of a number of research reports. Berenberg Bank lowered their price target on Haleon from GBX 503 to GBX 500 and set a "buy" rating on the stock in a report on Friday, August 8th. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a GBX 370 target price on shares of Haleon in a research note on Thursday, July 31st. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of Haleon in a research note on Friday, August 1st. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a GBX 440 target price on shares of Haleon in a research note on Wednesday, September 10th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of GBX 436.67.

Haleon Trading Down 0.5%

The company has a market cap of £30.29 billion, a PE ratio of 2,026.35, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The business has a 50 day simple moving average of GBX 359.52 and a two-hundred day simple moving average of GBX 379.09. The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported GBX 8.90 earnings per share for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. On average, analysts forecast that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Dawn Allen sold 64,329 shares of Haleon stock in a transaction on Monday, June 30th. The stock was sold at an average price of GBX 376, for a total value of £241,877.04. Insiders own 0.01% of the company's stock.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.